BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 2934950)

  • 1. Influence of a bagasse glucan (B0) on leukocyte aggregation and accumulation.
    Li XY; Damerau B; Vogt W
    Zhongguo Yao Li Xue Bao; 1985 Jun; 6(2):137-40. PubMed ID: 2934950
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of particulate beta-1,3 glucan on human, rat, and guinea pig complement activity.
    Glovsky MM; Cortes-Haendchen L; Ghekiere L; Alenty A; Williams DL; Di Luzio R
    J Reticuloendothel Soc; 1983 May; 33(5):401-13. PubMed ID: 6601707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor.
    Czop JK; Austen KF
    J Immunol; 1985 Nov; 135(5):3388-93. PubMed ID: 4045195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxiagin from the Naja oxiana cobra venom is the first reprolysin inhibiting the classical pathway of complement.
    Shoibonov BB; Osipov AV; Kryukova EV; Zinchenko AA; Lakhtin VM; Tsetlin VI; Utkin YN
    Mol Immunol; 2005 Jun; 42(10):1141-53. PubMed ID: 15829304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the complement system and leukocyte recruitment by Tityus serrulatus scorpion venom.
    Bertazzi DT; de Assis-Pandochi AI; Talhaferro VL; Caleiro Seixas Azzolini AE; Pereira Crott LS; Arantes EC
    Int Immunopharmacol; 2005 Jun; 5(6):1077-84. PubMed ID: 15829423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of complement activation profile during cardiopulmonary bypass and its inhibition by FUT-175.
    Miyamoto Y; Hirose H; Matsuda H; Nakano S; Ohtani M; Kaneko M; Nishigaki K; Nomura F; Kitamura H; Kawashima Y
    Trans Am Soc Artif Intern Organs; 1985; 31():508-11. PubMed ID: 3837498
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of decomplementation on mercuric chloride-induced glomerulonephritis in Brown-Norway rats.
    Capron M; Bascou C; Vial MC; Grossetete J; Hinglais N; Girard JF; Druet P
    Clin Exp Immunol; 1982 Sep; 49(3):611-7. PubMed ID: 6216993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salt-sensitivity of complement (C)-consumption induced by anticomplementary antigens and antigen/antibody complexes.
    Gancevici G; Popescu C; Toporan M
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):239-50. PubMed ID: 6818928
    [No Abstract]   [Full Text] [Related]  

  • 9. The leukokinetic changes and complement activation associated with filtration leukapheresis.
    Nusbacher J; Rosenfeld SI; Leddy JP; Klemperer MR; MacPherson JL
    Exp Hematol; 1979; 7(4 Suppl):24-30. PubMed ID: 400706
    [No Abstract]   [Full Text] [Related]  

  • 10. [Alternative complement activation pathway. Its mechanism, importance and quantitative determination].
    Gancevici GG; Popescu C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1984; 29(3):209-21. PubMed ID: 6390651
    [No Abstract]   [Full Text] [Related]  

  • 11. Action of a new non-steroid anti-inflammatory drug, carprofen (Ro 20-5720) on activation of the complement system: an in vitro research.
    Auteria A; Laghi Pasini F; Di Perri T
    Int J Tissue React; 1982; 4(1):9-13. PubMed ID: 7085003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface-bound capsular polysaccharide of type Ia group B Streptococcus mediates C1 binding and activation of the classic complement pathway.
    Levy NJ; Kasper DL
    J Immunol; 1986 Jun; 136(11):4157-62. PubMed ID: 3517165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement pathway activity in the opsonization of cefotaxime-treated Escherichia coli by normal human serum.
    Shaio MF; Chang FY; Chou MY
    Taiwan Yi Xue Hui Za Zhi; 1988 Jul; 87(7):712-20. PubMed ID: 3074153
    [No Abstract]   [Full Text] [Related]  

  • 14. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
    Inada K
    Jpn J Exp Med; 1980 Feb; 50(1):13-21. PubMed ID: 6770130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of concanavalin A on the hemolytic activity of the components of the classical complement pathway.
    Gee AP; Boyle MD; Langone JJ
    Mol Immunol; 1980 Jan; 17(1):143-6. PubMed ID: 7360112
    [No Abstract]   [Full Text] [Related]  

  • 16. Eosinophil granule major basic protein regulates generation of classical and alternative-amplification pathway C3 convertases in vitro.
    Weiler JM; Gleich GJ
    J Immunol; 1988 Mar; 140(5):1605-10. PubMed ID: 3346544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the classical pathway of complement by tobacco glycoprotein (TGP).
    Koethe SM; Nelson KE; Becker CG
    J Immunol; 1995 Jul; 155(2):826-35. PubMed ID: 7608560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of circulating white blood cells in the enhancement of antigen-induced bronchoconstriction after intravascular complement activation with cobra venom factor.
    Regal JF; Fraser DG
    Ann N Y Acad Sci; 1991; 629():388-91. PubMed ID: 1952561
    [No Abstract]   [Full Text] [Related]  

  • 19. Serine protease inhibitor nafamostat given before reperfusion reduces inflammatory myocardial injury by complement and neutrophil inhibition.
    Schwertz H; Carter JM; Russ M; Schubert S; Schlitt A; Buerke U; Schmidt M; Hillen H; Werdan K; Buerke M
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):151-60. PubMed ID: 18670364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapsone and complement.
    Schifferli JA; Jones RR
    Lancet; 1981 Aug; 2(8242):368-9. PubMed ID: 6115143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.